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Continued improvements in embryo culture media composition allow for the 
growth of high quality blastocysts, which can be used to derive embryonic stem 
cells (ESCs).  ESCs are capable of becoming any cell type in the body making 
them a valuable research tool for therapeutic and regenerative research, while 
furthering our understanding of embryonic development and cell differentiation.  
The domestic cat is an important model species for both human medicine and 
wild felids.  Cat embryo culture produces blastocysts at a rate far below that of the 
mouse and initial attempts at deriving cat ESCs have resulted in embryonic stem-
like cells, which cannot be maintained indefinitely.  In this study we assessed and 
compared the quality of cat blastocysts produced in vitro using two commercial 
human blastocyst growth media, and the maintenance of pluripotency markers 
OCT-4 and NANOG in inner cell mass explants from in vitro produced 
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Chapter 1: Literature Review 
1.1 Introduction 
The culture of embryos in vitro has allowed for advancements in assisted 
reproductive technologies such as embryo transfer, embryo sexing, genetic 
diagnosis, and has provided a better understanding of early embryonic stages.  
The composition of the media used in embryo culture has evolved over the years 
from simple salt solutions and complex media more suited to tissue culture to 
media specifically designed for optimal development (Herrick et al., 2007).  Yet 
despite this progress there is still plenty of room for advancement.  Continued 
improvements in media composition allow for the growth of high quality 
blastocysts, which can be used in advanced technologies such as embryonic stem 
cell (ESC) derivation. 
Derived from various stages of preimplantation embryos, ESCs can 
remain in a pluripotent state and are capable of becoming any cell type in the 
body.  This plasticity makes ESCs a valuable research tool for both therapeutic 
and regenerative research, while simultaneously furthering our understanding of 
embryonic development and cell differentiation.  While ESCs hold much promise 
for research via their ability to be genetically manipulated and differentiated in 
culture, it has been thirty years since the first naïve mouse ESCs (mESCs) were 
derived, and advancements in other species has been limited and slow.  Naïve or 
ground-state ESCs are characterized by the ability to become any type of cell 




markers, self-renewal capabilities, and have a normal karyotype.  To be a 
validated naïve ESCs, the cells must be able produce a chimeric embryo and to 
contribute to the germ line of the resulting chimeric animal.  Primed ESCs are 
similar to naïve but have slightly different morphology, cytokine dependencies, 
and do not contribute to the germ-line (Boyer et al., 2005).   
Validated ESCs from the domestic cat would be advantageous as cats are a 
unique model species for both human medicine and exotic and rare wild felids. 
Derivation of domestic cat ESCs have shown promising results, however these 
initial attempts have resulted in embryonic stem-like (ES-like) cells that cannot be 
maintained indefinitely in culture without differentiating or losing the ability to 
self-replicate.  Domestic cat embryos have been cultured in vitro for years, yet the 
rates of blastocyst formation are far below those of the mouse, demonstrating 
room for improvement in culture techniques.  Techniques developed for the 
domestic cat can be easily translated to large and small wild felids for 
conservation biology purposes.  
The main objectives of this study were to: 
1. Determine whether protein source affected embryo quality.  Our 
hypothesis was that Medium A with a defined protein source would be 
superior to Medium B with a semi-defined protein source for growing 
domestic cat blastocysts.  More specifically, Medium A contained serum 
protein substitute while Medium B contained both fetal bovine serum 
(FBS) and bovine serum albumin (BSA), which can have differing, and 




fertilization or later staged culture (Dobrinsky et. al., 1996; Karja et al., 
2002; Wood et. al., 1995). 
2. Derive naïve ESC using 3 different culture conditions.  Our hypothesis 
was that cat inner cell mass (ICM) explants would show preference for a 
cocktail of small inhibitory molecules rather than previously used cytokine 
cocktails for cat ES-like cells or the currently used cytokine cocktail for 
mESC culture.  By necessity, cytokines used in cat studies are of human or 
mouse origin, and we believe that the small molecules will be able to 
overcome the species-specificity that has been shown with cytokine 
receptors (Wilcox et al., 2009).   
 
It is hoped that the findings of this research will further elucidate the 
effects of protein source on embryo culture and provide insights into pluripotency 
pathways in the domestic cat, helping to remove some of the difficulty inherent 




1.2 The domestic cat 
There are 36 known species of felids in the world today, of which 16 are 
listed as at least vulnerable, if not endangered, on the IUCN Red List.  Twenty-
nine species are considered decreasing in population size (“IUCN Red List of 
Threatened Species,” 2012).  The domestic cat has been used as a model species 
for wild cats for artificial reproductive technologies for many years (Graves-
Herring et al., 2011; Wildt et al., 2010).  Cats are smaller and easier to obtain than 
their exotic cousins, allowing for more research to be conducted more readily.  
The domestic cat reproduces well in a laboratory setting; it reaches maturity 
quickly and lives longer than mice, providing an advantageous model for human 
biomedical research.  
There is an ever-growing pool of information about culturing embryos in 
the domestic cat.  Embryonic development in the cat is very similar to other 
eutherian mammals.  In vitro, an oocyte can be matured in the presence of follicle 
stimulating hormone  (FSH), luteinizing hormone (LH) and estradiol (E2).   
Matured oocytes can be fertilized and cultured until they reach the blastocyst 
stage.  After fertilization, the domestic cat embryo undergoes an initial wave of 
embryonic transcription (Waurich et al., 2010).  At 1-day post insemination, the 
embryo divides into 2 cells, and at 2 days post insemination, the embryo consists 
of 4 cells (Waurich et al., 2010).  At the 5 to 8 cell stage, a second wave of 
embryonic gene transcription occurs also referred to as maternal-to-embryonic 
transition (MET) (Filliers et al., 2011; Hoffert et. al., 1997, Waurich et al., 2010).  




al., 2010).  As the morula develops into the blastocyst stage, the cells differentiate 
into two populations, the cells of the trophectoderm (TE) and those of the ICM.  
The embryo enters the blastocyst stage 6 days post insemination, expands by day 
7 and hatches out of the zona pellucida by 7.5 days (Filliers et al., 2011).  In vivo, 
domestic cat embryos enter the uterine horn between day 6 to 7, during the 
transition from morula to early blastocyst, and attach to the uterus through an 
endotheliochorial placenta 12 to 13 days post insemination (Boomsma et. al., 
1991).  The ICM will undergo a second differentiation into primitive endoderm 
and epiblast.  The epiblast will become the embryo proper while primitive 
endoderm contributes to the extraembryonic membranes (Bianchi et. al., 1993; 
Luckett, 1978).  
Studying in vitro embryo production media in various species has revealed 
that the requirements of preimplantation embryos are species and stage specific.  
Multiple protocols have been developed to culture cat embryos in vitro with 
varying success in blastocyst formation (Waurich et. al. 2012).  One interesting 
study sought to make a feline optimized culture medium by identifying precise 
molar concentrations of ions, carbohydrates, amino acids, vitamins and serum 
necessary for early embryonic growth (Herrick et al., 2007).  Previous studies 
have examined the importance of protein source when culturing embryos of cat 
and pig in vitro (Dobrinsky et al., 1996; Karja et al., 2002; Wood et al., 1995).  
Complex biological macromolecules are used in many culture systems across 
species as a source of protein and nutrients.  However, FBS has been found to 




more oocytes to be fertilized (Wood et al., 1995).  Interestingly, more embryos 
reach the hatching blastocyst stage and have higher cell number with FBS rather 
than BSA for fertilization and culture (Dobrinsky et al., 1996; Han & Niwa, 2003; 
Herrick et al., 2007; Karja et al., 2002).   
Further complicating these studies is the effect of FBS on oocyte and 
embryo tolerance to cryopreservation.  Several studies in the bovine have reported 
increased success in blastocyst survival after cryopreservation when cultured in a 
serum free system (Abes et. al., 2002; George et al., 2008; Gomez et al., 2008; 
Mucci et al., 2006; Ohboshi et al., 1997; Rizos et al., 2003; Shamsudden et. al., 
1994).  Studies in the cat has shown that addition of FBS to culture media 
increased embryo sensitivity and resulted in decreased post-thaw viability of 
expanding blastocysts after vitrification, compared to serum free culture 
conditions (Murakami et al., 2011; Swanson et. al., 1999).  Addition of serum can 
cause an accumulation of lipid droplets, which contribute to this decrease in 
freezing success.  As a defining characteristic of cat oocytes is the dark cytoplasm 
due to a high concentration of lipid droplets, a serum free culture method that 






1.3 Embryonic Stem Cells 
Background 
In mammals, stem cells can be divided into two categories: adult and 
embryonic.  ESCs have the potential capacity to grow in vitro indefinitely without 
differentiating. ESCs were derived first from the ICM of mouse blastocysts 
(Evans & Kaufman, 1981; Martin, 1981).  Currently mESCs can be derived from 
an 8-cell embryo (Tesar, 2005), morula (Tesar, 2005), and primitive ectoderm of 
implantation-delayed blastocysts (Prelle, et al. 2002).  ESCs can be differentiated 
in vitro into the three germ layers (endoderm, mesoderm, and ectoderm), 
including further induction into more differentiated cell types by applying the 
proper culture conditions.  ESCs are also capable of differentiating into primordial 
germ cells (PGCs), another pluripotent cell type that is isolated from the genital 
ridge of post-implantation embryos (S. Liu et al., 2004).  Due to the ability to 
differentiate into so many cell types, stem cells are an invaluable research model 
for the study of development (O’Shea, 1999) and disease (Comizzoli et al., 2010; 
Travis et al., 2009; Wildt et al., 2010).  
Validated ESCs are those which can contribute to the germ line after being 
injected into a blastocyst stage embryo, producing chimeric offspring that have 
the ESC descendants represented throughout the organism, including germ cells 
(Kehler et al., 2005).  Currently, fully validated ESCs have been derived in the 
mouse (Evans & Kaufman, 1981; Martin, 1981), and rat (P. Li et al., 2008).  
Human ESCs (hESCs) cannot be tested for germline capabilities due to ethical 




There are two types of ESC: naïve ESC (e.g., typical ICM derived mESC), 
and epiblast derived stem cells (EpiSC, e.g., hESC and mouse EpiSC derived 
from the epiblast).  Naïve mESC lines are dependent on leukemia inhibitory 
factor (LIF)/Signal transducer and activator of transcription 3 (STAT3) signaling 
for maintenance of pluripotency (Hall et al., 2009) and bone morphogenetic 
protein 4 (BMP4) for self-renewal and resistance to differentiation (Ying et al., 
2003).  When fibroblast growth factor (FGF2) and ACTIVIN/ Transforming 
growth factor beta (TGF-β) signal transduction pathways are activated, mESCs 
have a tendency to differentiate (Li et al., 2009).  Naïve ESC can be genetically 
manipulated via the addition or deletion of genes before being injected into a 
blastocyst, giving rise to a modified whole animal chimera (Evans, 2005; Wobus 
& Boheler, 2005).  This ability allows the mouse to be a wonderfully useful 
mammalian model for biomedical research and may lead to other, physiologically 
more relevant models such as domestic cats upon production of validated ESC in 
these other species.   
Human and primate ESCs are examples of primed ESCs.  Their colonies 
look different from mESC colonies in that they have a more flattened colony 
morphology and have dependence on FGF2 and TGF-β / ACTIVIN/NODAL 
signaling rather than on LIF/STAT3 for maintenance of their pluripotency 
(Dvorak et al., 2005; Xu et al., 2005).  When exposed to BMP4, hESC 
differentiate quickly (Das et al., 2007; Xu et al., 2002).  The term “ES-like” is 
used for cell lines that have not yet had proven germline transmission.  While 




transfer (Keefer et al., 1994), they typically cannot be maintained in culture and 
may have abnormal morphology or expression patterns of pluripotency markers.  
ES-like cells have been developed for the rabbit (Fang et al., 2006; Intawicha et 
al., 2009), baboon (Simerly et al., 2009), rhesus macaque (Mitalipov et al., 2006), 
marmoset (Thomson et al., 1996), cynomolgus monkey (Suemori et al., 2001), 
chicken (Pain et al., 1996), mink (Sukoyan et al., 1993), hamster (Doetschman et 
al., 1988), pig (Brevini et al., 2007; Wheeler, 1994), bovine (Mitalipova et al., 
2001; Saito et al., 2003; Stice et al., 1996; Wang et al., 2005), water buffalo 
(Huang et al., 2010), ovine (Dattena et al., 2006; Notarianni et al., 1991), canine 
(Hatoya et al., 2006; Hayes et al., 2008; Wilcox et al., 2009), and goat (Behboodi 
et al., 2011), along with initial progress in other species.  Putative success has also 
been achieved in the domestic cat (Gómez et al., 2010; Yu et al., 2008).  ES-like 
cells cannot yet produce chimeric offspring nor can they be maintained 
undifferentiated indefinitely in culture. 
 
Derivation and culture of ESCs 
Derivation of ESCs from preimplantation embryos can be accomplished 
by placing a hatched or zona-free blastocyst-stage embryo on a layer of feeder 
cells and culturing the ICM region in vitro.  Multiple techniques involving culture 
of both intact and dissected blastocysts have been used successfully in mice 
(Evans & Kaufman, 1981; Kobolak et al., 2010).  The ICM may be enzymatically 
separated from the TE of the blastocyst, as is done during typical hESC culture 




cells to remove them from the ICM (Solter & Knowles, 1975).  Microdissection 
can also be used to mechanically separate the ICM from the TE and cultured 
separately. Although some TE may remain attached, this method has been used 
successfully in hESC and mESC derivation (Illmensee & Hoppe, 1981; Skottman 
& Hovatta, 2006; Ström et al., 2007).  
In most procedure, the ICM explants are grown on a layer of mitotically-
blocked feeder cells (Evans & Kaufman, 1981; Gómez et al., 2010; Y. Liu et al., 
2011).  For domestic cat ES-like cell culture, cat dermal fibroblasts provided 
better cell support for the initial attachment of plated ICMs, generated higher 
numbers of ES-like cells and maintained more prolonged self-renewal in an 
undifferentiated state than using mouse feeder cells (Gómez et al., 2010).  This 
demonstrated that cell-surface and soluble factors that support self-renewal and 
prevent differentiation provided by feeder layer cells may be species specific.  
The optimal conditions for deriving novel ES cell lines may differ from those 
required for maintenance.  In the pig, homogenous feeder cells were better for 
starting initial cultures but mouse cells proved better for maintenance (Strojeck et 
al., 1990).  For dog ES-like cells, homologous and heterologous feeders equally 
supported initial cultures, but mouse feeder cells were superior for continued 
growth (Wilcox et al., 2009).  Having a dense feeder layer is important and should 
not be overlooked. 
 
Stem cell progress in the domestic cat 




(Gómez et al., 2010; Serrano et al., 2005; Yu et al., 2008).  In vivo produced cat 
blastocysts generated cat ES-like cells in culture for up to 8 passages (Yu et al., 
2008).  Knockout serum replacer (KSR) medium allowed ICM cells to attach 
better and form domed colonies, while FBS medium formed flat colonies and had 
higher cell proliferation (Yu et al., 2008). When ICM cells from in vitro 
blastocysts are explanted for ESC culture, the colonies produced had a tightly 
packed, dome shaped morphology, alkaline phosphatase activity, and readily 
expressed the markers genes OCT-4, SSEA-1, NANOG, SOX2 and C-MYC, 
similarly to what is seen in whole blastocysts, although expression levels of 
colonies were at a lower level than blastocysts (Gómez et al., 2010).  ES-like cells 
have also been shown to be positive for SSEA-1, SSEA-3, and SSEA-4 (Yu et al., 
2008).  Several studies have verified that cat ES-like cells seem to survive 
undifferentiated and proliferate longer when grown on a homologous feeder layer 
of blocked cat fibroblast cells (Gómez et al., 2010; Serrano et al., 2005; Yu et al., 
2008).  Reports on the best way to passage domestic cat ES-like cells are 
conflicting, both passaging via enzymatic and mechanical dissociation can 
stimulate cells to differentiate (Gómez et al., 2010; Yu et al., 2008).  These 
studies have demonstrated short-term culture can be obtained, however neither 
has been able to maintain ESC characteristics greater than 102 days (Gómez et al., 
2010; Yu et al., 2008). 
The quality of ESCs produced is reliant on the quality of the initial starting 
material.  It has been shown in other species that in vivo produced embryos have 




2004). Typically, in vivo produced embryos have higher expression levels of the 
common pluripotency markers, however in vitro embryos are much easier to 
obtain for many species.  It is important for the continued advancement of ESC 
culture that high quality blastocysts be produced in vitro.  A domestic cat ESC 
line will be a valuable non-murine model for studying comparative diseases and 
developmental disorders in the human.  As the domestic cat is already used as a 
model of assisted reproductive technologies for wild felids (Brown 2011), the 
domestic cat can be used as a foundation for future ESC research in endangered 
felids.  Establishing efficient ESC derivation techniques in the domestic cat will 
drastically reduce the number of embryos needed from rare feline species.  When 
future attempts are made at producing rare felid ESCs, the proper ESC culture 
conditions can be more quickly obtained by starting with the cytokine conditions 
that best maintain domestic cat ESCs. 
 
Optimization of ESC Culture Systems 
Cytokines are small cellular molecules that, when added to the culture 
medium, can activate or inhibit receptors.  For the culture of ESCs, cytokines are 
added to the medium to stimulate appropriate pathways within the cells, 
promoting a continuation of the stem-state, or differentiation if desired.   Mouse 
and human ESCs are cultured using different cytokines, possibly reflecting the 
difference between naïve and EpiSC stem cell types.  Traditionally, mESCs are 
cultured using LIF (leukemia inhibitory factor), sometimes in combination with 




growth medium used (Ying et al., 2003).  LIF activates STAT3 (signal transducer 
and activator of transcription-3) which directs ESC self-renewal (Matsuda et al., 
1999; Niwa et al., 1998).  In vertebrate embryos, BMPs are well known anti-
neural factors (Wilson & Hemmati-Brivanlou, 1995; Wilson & Edlund, 2001) and 
have been shown to antagonize neural differentiation of ESCs (Tropepe et al., 
2001; Ying et al., 2003).  When given alone, BMP promotes differentiation of 
ESC into non-neural fates, but in combination with LIF self-renewal is enhanced, 
resulting in highly pure populations of undifferentiated ESCs after 2 to 3 passages 
(Ying et al., 2003). 
When attempting to derive ESCs from a novel species, cytokines like LIF 
may not yet be available for the novel species; it is critical to use a type of LIF 
that is closely related to and will cross react with the species of interest.  One 
study found that canine and mouse LIF receptors (LIFR) are responsive to human 
LIF, but human LIFR is not responsive to mouse LIF.  As human and canine are 
75% homologous to murine, they used human LIF in this study (Wilcox et al., 
2009).  The optimal cytokines would be from the species of interest, however 
isolating or producing recombinant proteins is time consuming and costly.  An 
alternative to species-specific cytokines exists.  Small molecules have been 
developed that have parallel functions compared to known cytokines, without the 
species-specific requirement of the cytokine.  These small molecules usually 
exhibit a longer life in culture medium than the counterpart cytokine.  The 




better maintain undifferentiated proliferation of pluripotent ESCs for indefinite 
periods of time.   
Small molecules should be more useful across species for maintenance of 
pluripotency, rather than using the traditional semi-defined media supplemented 
with cytokines, such as LIF. A novel protocol for isolation of mouse and rat ESC 
involves cocktails of two or three small inhibitory molecules, called the “2i” or 
“3i” method (Li et al., 2009).  These inhibitory small molecules block specific 
cellular pathways, allowing for continued self-renewal or maintenance of 
pluripotency factors.  Small inhibitory molecules have been shown to be useful in 
non-mouse species to maintain pluripotency.  There are several combinations of 
inhibitors that one might choose; we chose one version of “3i,” which consists of 
CHIR99021, PD0325901, and PD173074.  This 3i cocktail targets the FGF, 
MEK, and GSK3 pathways.  This particular cocktail has enabled efficient 
derivation and subsequent propagation of germline competent ESCs from several 
mouse strains, as well as maintaining OCT-4 and NANOG expression longer than 
in traditional mouse culture (Buehr et al., 2008; Ying et al., 2008).  CHIR99021 
selectively inhibits both GSK3α and GSK3β (Buehr et al., 2008; Murray et al., 
2004).  The molecule inhibitor PD0325901 inhibits MEK (via ERK), eliminating 
the MAPK signal that induces differentiation (Lee et al., 2012).  When 
CHIR99021 and PD0325901 were used on reprogrammed porcine embryonic 
fibroblast cells, the cells demonstrated a similar colony morphology to naïve 
mESCs, were dependent on LIF to remain undifferentiated, expressed 




interval, a normal karyotype, and were able to generate teratomas (Telugu et al., 
2010).  This example supports our hypothesis that a “3i” method will support 





1.4 Markers of Pluripotency 
Major Transcription Factors 
OCT-4, NANOG, and SOX2 work cooperatively to regulate expression of 
genes in pluripotent cells.  Due to their essential role in early embryonic 
development, NANOG, OCT-4 and SOX2 are the most commonly used markers 
of pluripotency in ESCs (Boyer et al., 2005).  A null mutation for any of these 
genes is lethal to an embryo; the embryo cannot maintain pluripotent cells and 
cannot differentiate appropriately to undergo normal gastrulation (Masui et al., 
2007).  Homeodomain transcription factors, such as NANOG and OCT-4, are 
characterized as being evolutionarily conserved in sequence, but have species-
specific difference in expression patterns  
 While these genes have distinct roles, the pathways they affect are 
interconnected and disruption of one factor may result in developmental 
consequences for the embryo (Boyer et al., 2005).  The three factors influence 
each other’s transcription, leading to a rapid loss of pluripotency if one factor is 
altered.  SOX2 and OCT-4 can form a dimer before or after the proteins bind 
DNA; both proteins are often necessary for efficient binding of the promoter and 
expression of a gene (Boyer et al., 2005).  In fact, more than 90% of the promoter 
regions of genes that are bound by both OCT-4 and SOX2 are also bound by 
NANOG in close proximity (Boyer et al., 2005).  These three proteins together 
occupy a minimum of 353 genes, demonstrating their broad control of 
transcription in hESC (Boyer et al., 2005).  As is seen with SOX2, over-




2005; Rodda et al., 2005).  Rescue of expression can occur in some instances: for 
example over-expression of OCT-4 can rescue the pluripotency of SOX2-null 
mESCs (Boer et al., 2007).  
 
OCT-4 
OCT-4 is a POU domain transcription factor, also known as POU5F1 for 
POU domain, class 5, transcription factor 1.  The POU family of proteins is 
characterized as being highly conserved across species.  POU is an acronym for 
Pituitary-specific Pit-1, Octamer transcription factor protein and neural Unc-86 
transcription factor.  It is expressed in unfertilized oocytes, early embryos, ICM 
cells, epiblast, pregastrulation embryos, and in primordial germ cells of mice 
(Babaie et al., 2007).  It is also associated with lineage differentiation during 
blastocyst formation (Babaie et al., 2007).  Maternally derived OCT-4 mRNA can 
be detected in the mouse ovum through the 4-cell stage and the bovine ovum 
through the 8-cell stage (Kurosaka, et al. 2004).  In the mouse, zygotic expression 
of OCT-4 begins at the 4-cell stage and later becomes restricted to the ICM cells 
of the blastocyst (Boiani & Schöler, 2005; Yeom et al., 1996).  
In human and mouse ESCs, OCT-4 expression becomes reduced when 
these cells differentiate and lose their state of pluripotency (Ginis et al., 2004).  A 
knockdown of OCT-4 in mESCs resulted in elevated expression of TE genes 
(cdx2), and endodermal markers (gata6) (Hay et al., 2004).  In mESCs, 
differentiation into endoderm and mesoderm, or into TE, can be induced by 




range (Niwa et al., 2000).  Similarly, up-regulation of OCT-4 in mESCs can 
induce extra-embryonic endoderm and mesoderm lineages, which is functionally 
similar to a lack of LIF (Niwa et al., 2000).  Exclusive OCT-4 expression is not 
sufficient to maintain undifferentiated mESCs; a cooperative LIF signal is 
required to maintain pluripotency (Niwa et al., 2000).  
 
NANOG 
NANOG is a divergent NK2 homeodomain transcription factor 
responsible for maintaining the self-renewal properties of ESCs (Mitsui et al., 
2003).  NANOG has a role in many important cellular mechanisms, including the 
regulation of transcriptional repression in the epiblast and the transcription of 
histone methyltransferases and telomeric proteins (Villasante et al., 2011).  In the 
mouse, Nanog mRNA has been detected as early as the morula stage, and can be 
found later in the ICM of blastocyst stage embryos (Avilion et al., 2003), as well 
as in the proximal mouse epiblast at E6, and in the nascent gonad at E11.5 to 
E12.5 (Hart et al., 1994).   
In mESCs, differentiation causes a reduction in Nanog expression (Hart et 
al., 2005).  Nanog over-expression in mESCs promotes growth independent of 
LIF supplementation (Chambers et al., 2003), as well as a resistance to induced 
differentiation (Loh et al., 2006).  The over-expression of Nanog in hESCs 
enables continued propagation of pluripotent cells over several passages 






The transcription factor SOX2 (SRY-related HMG box 2) is essential for 
pluripotent cell development.  In the mouse, SOX2 is expressed in the 4-cell 
embryo, and remains in both the ICM and TE cells in blastocysts (Masui et al., 
2007), later becoming restricted to the epiblast (Avilion et al., 2003).  Trophoblast 
stem cells cannot be obtained from Sox2-null mouse embryos, signifying that 
SOX2 is needed for the development of trophoblast (Masui et al., 2007).  
Interestingly, Sox2-null embryos cannot express Cdx2 (Masui et al., 2007).  
Expression of Sox2 can be rescued by forced expression of OCT-4 (Masui et al., 
2007).  Due to the dimeric nature of SOX2 and OCT-4, the expression patterns of 
the two proteins are very similar.  Sox2 was present in higher levels at the morula 
stage than the blastocyst stage in domestic cat in vitro embryos, as well as higher 
levels of Sox2 in vitro than in vivo (Filliers et al., 2011).  In mouse embryos, 
higher levels of Sox2 were found in blastocysts compared to morulae (Avilion et 
al., 2003). 
Relevant Pathways 
The activation and inhibition of cellular signaling pathways is the key to 
maintaining pluripotency in ESCs.  While many core pathways are conserved, 
species-specific differences necessitate further analysis in each new ESC 
derivation.  The culture techniques used for mouse and human ESCs provide a 
technical starting point for ESC culture of new species.  The relevant pathways in 
these two models are similar and, in both the mouse and human, there is cross talk 




cascades in the presence of ligand-bound receptors, the signal from which is 
transferred to the nucleus (Figure 1).  Here, transcription of key genes can be 
enhanced or impaired.  These genes control various cellular functions including 
differentiation and self-renewal. Small molecules, or cytokines, can be used to 




Leukemia inhibitory factor is a member of the LIF-oncostatin M-I1-6 
superfamily of cytokines.  Supplementation with LIF has eliminated the need for 
the mitotically inactivated fibroblast co-culture system when culturing mESCs 
(Evans & Kaufman, 1981; Smith et al., 1988).  LIF participates in a heterodimeric 
cell surface receptor complex consisting of LIFR (the LIF receptor subunit, 
Gearing et al., 1992) and glycoprotein 130 (GP130, Davis et al., 1993).  In the 
absence of maternal LIF, blastocysts enter a stage similar to delayed implantation 
(Stewart, 1994).  Embryos that lack either LIFR or GP130 are able to develop 
beyond gastrulation (Dani et al., 1998); since these embryos make it to 
gastrulation, this suggests that there might be an alternative mechanism to 
maintain pluripotency in vivo than what has been seen for in vitro ESC cultures.  
When LIF binds to the LIFR, it induces the formation of a LIFR-GP130 
heterodimer.  This mechanism activates the Jak pathway, causing the tyrosine 
phosphorylation of GP130 and providing a binding site for proteins on the 










Figure 1: A summary of pathways relevant to embryonic stem cells: RTK, PI3K, 







GP130 leads to the activation of STAT 1 and 3, as well as ERK 1 and 2 and PI-
3K, as seen in Figure 2 (Cavaleri & Scholer, 2003).  Stimulation of 
Ras/Raf/MEK/ERK leads to differentiation in mESCs (Burdon et al., 1999).  LIF 
maintains pluripotency in mESCs by restricting the GSK3 pathway, and allowing 
β-catenin to translocate to the nucleus and lead to transcription (Buehr et al., 
2008).  Conversely, it has been shown that the activation of MEKs or ERKs, can 
overcome differentiation in mESCs and promote self-renewal (Burdon et al., 
1999). A dominant form of STAT3 can be used in place of LIF for mESC 
pluripotency maintenance (Matsuda et al., 1994). While hESCs similarly express 
LIF and GP130 receptors, using dominant active STAT3 is insufficient to 
maintain the undifferentiated state (Humphrey et al., 2004). In hESCs, the use of 
added LIF is insufficient in maintaining pluripotency, and BMPs induce rapid 
differentiation.   
TGF-β  Pathway 
The Transforming Growth Factor-β (TGF-β) pathway has two branches: 
the TGF-β/Activin/Nodal and the BMP subfamily.  Both branches of the pathway 
are activated by a ligand inducing two Type-I receptors and two Type-II 
receptors, thus forming a complex of four receptors and one ligand.  In the first 
branch, BMP ligands bind the extracellular ligand-binding domain of two Type-I 
BMP receptors. This complex then binds the Type-II receptor, resulting in a 
tetramer.  On the other branch of the pathway, a TGF-β or Activin ligand will 
bind to the two Type-II receptors, which then joins with two Type-I receptors (Shi 













Figure 2: The interactions of LIF and the MEK/ERK and JAK-STAT pathways: 
When LIF is present in embryonic stem cells, the cells are able to self-renew, 
while alternative pathways keep differentiation, which is promoted by activation 
of the MEK/ERK pathway, reduced. The addition of PD0325901 exhibits a 








form a complex with SMAD 4, which can then translocate to the nucleus and bind 
to promoters of target genes, affecting transcription (Varga & Wrana, 2005).  
SMAD 6 and 7 can inhibit SMAD 1 and 5 and both branches of the TGF-β 
signaling pathway, respectively.  Activation of TGF-β/Activin/Nodal branch 
through SMAD 2 and 3 is associated with pluripotency.  
The other branch of the TGF-β family is the BMP subfamily.  BMP4 
induces differentiation into mesoderm and ectoderm when not in the presence of 
LIF in mESCs (Ying et al., 2003, Figure 3).  When LIF is present without the 
influence of BMP4 or FBS, cells undergo neural differentiation.  Thus, BMP4 can 
be said to block neural differentiation.  It also is responsible for inhibiting the 
MAPK pathway (Qi et al., 2004), blocking differentiation.  When BMP and LIF 
are present together, mESCs experience extended self-renewal (Ying et al., 2003).  
BMP signaling itself is unable to support self-renewal and is associated with 
trophoblast or extraembryonic endoderm cell differentiation in hESCs.  In hESCs, 
BMPs promote differentiation.  NOGGIN is responsible for preventing endoderm 
differentiation and has been used to induce differentiation into neural lineage by 
inhibiting BMP4 (Pera et al., 2004).  Basic FGF and BMP4 lead to TE 
differentiation in hESCs grown without a feeder layer (Xu et al., 2002). However, 
it has been found that a balance of FGF signaling, TGF-β/Activin and BMP 











Figure 3: The Role of LIF and BMP4 in mESCs: LIF and BMP4 have differing 
effects on ESCs, however, when the two are combined, an alternative phenotype 
is seen: longer self-renewal in ESCs.  Noggin can inhibit BMP4 and induce neural 






Fibroblast growth factors (FGFs) affect several areas of embryonic 
development such as cell proliferation, differentiation, and migration.  FGFs bind 
and activate several types of receptor tyrosine kinases (RTKs), designated as FGF 
 Receptors 1-4 (FGFR1-4).  During development, FGFs play a diverse and critical 
role in organogenesis, demonstrated by the lethal null mutations of several FGF 
molecules (Eswarakumar et al., 2005).  FGF-stimulation can lead to an activation 
of Ras/MAPK pathway and PI3K signaling (Eswarakumar et al., 2005).  
Interestingly, an FGF2 (also known as basic FGF or bFGF) enhancer region exists 
downstream from the coding region activated by OCT-4 and SOX2 
(Eswarakumar et al., 2005).  Once present, FGF2 can increase the continued 
proliferation of undifferentiated hESCs (Amit et al., 2000) as well as activate PI-
3K to promote self-renewal without serum or feeder cells (Wang et al., 2005).  
AKT, (which is activated downstream by PI3K) also promotes cell proliferation, 
survival, growth, and motility. 
When the FGF ligand binds the extracellular portion of the fibroblast 
growth factor receptor, two fibroblast growth factor receptor substrate 2 (FRS2) 
molecules bound to the domain inside the cellular matrix become phosphorylated, 
activating phospholipase Cγ (PLCγ) and growth factor receptor-bound protein 2 
(Grb2, Figure 4).  Grb2 activates both the Ras/Raf (leading to activation of the 
MAPK pathway and differentiation of mESC), and Gab1 (leading to PI3K 
activation).  When FGF binds its receptor and activates canonical MAPK/ERK 











Figure 4: FGF Pathway Interactions: When FGF ligand is present, the MAPK and 
PI3K pathways are activated.  This stimulates differentiation in naïve ESCs, but 
promotes the stem state in EpiSCs. The addition of PD173074 to culture medium 
inhibits the FGF receptor, deactivating the pathways that are usually stimulated by 






MAPK/ERK pathway in order to maintain pluripotency.  The small molecule 
PD173074 inhibits fibroblast growth factor receptor 3 (FGFR3).  This receptor 
molecule is ATP-competitive and cell-permeable, and FGFR3 loss in null mice 
results in bone overgrowth (Eswarakumar et al., 2005).  With PD173074 bound, 
differentiation is blocked. PI3K 
Phosphoinositide 3-kinase (PI-3K) is a group of enzymes that are 
responsible for phosphorylating phospholipids at the plasma membrane (Figure 
5).  When activated, the PI3K pathway leads to the activation of AKT, which is 
subsequently translocated to the plasma membrane.  Active AKT results in cell 
proliferation and survival via phosphorylation of many molecules.  When AKT is 
inhibited, blastocyst hatching can be significantly delayed (Riley et al., 2005).  PI-
3K appears to be very important for the maintenance of undifferentiated mESCs 
and hESCs based on dominant-negative mutant experiments and inhibitor 
treatments (Murakami et al., 2004; Paling et al., 2004).  PI-3K inhibits the 
RAS/MAPK pathway, possibly promoting self-renewal in mESCs and hESCs (Li 
et al., 2007).  NANOG transcription and protein levels decrease when PI3K was 
inhibited (Storm et al., 2007). 
 
WNT 
 The canonical WNT pathway inhibits GSK-3 mediated B-catenin 
destruction and leads to the stabilization, nuclear localization and transactivation 
of B-catenin (Figure 6).  WNT ligands have been shown to inhibit differentiation 






Figure 5: Relevant Interactions of the PI-3K Pathway: RAS/MAPK and AKT 
activation via PI3K lead to increased self-renewal in ESCs. mTOR and AKT 
activation via PI3K lead to increased proliferation of ESCs.  
 
 
Figure 6: Wnt Pathway: When Wnt ligand is present, β-catenin can translocate to 
the nucleus and lead to transcription. When Wnt is not present to inhibit GSK3-β, 
β-catenin is degraded.  Addition of CHIR99021 inhibits GSK3-β, allowing β-
catenin to accumulate and be translocated to the nucleus to assist in transcription.  
Either the addition of CHIR99021 or the presence of Wnt ligand promotes 


















resulting in low cytoplasmic presence.  In the presence of WNT, free B-catenin 
will accumulate in the cytoplasm and translocate to the nucleus where it binds 
downstream target gene promoters and results in differentiation into the neural 
lineage in hESC (Otero et al., 2004).  In mESCs, WNT ligand acts via the 
canonical pathway.  WNTs and LIF work synergistically to regulate STAT3 
activity; WNT leads to an increase in STAT3  mRNA and LIF promotes 
phosphorylation of STAT3 proteins, activating the pathway (Hao et al., 2006).  B-
catenin interacts with OCT-4 to up-regulate Nanog, it also interacts with NANOG 
and OCT-4 to assist in LIF dependent self-renewal in mESCs (Hao et al., 2006).  
NANOG reacts with SMAD1 to interfere with BMP and limit mesoderm 
differentiation, while also acting downstream of the LIF-Jak/STAT pathway 
(Gilbert, 2010). 
The small molecule CHIR99021 selectively inhibits GSK3β, and thus 
differentiation.  This is similar to the LIF activity in which the presence of LIF 
deactivates GSK3β via the PI3K/AKT pathway, β-catenin can accumulate and 
move into the nucleus where it binds DNA with Oct3/4 protein to up-regulate 




1.5 Comparative Mammalian Blastocyst Development 
A necessary pool of maternal RNA is present in the mammalian oocyte to 
help the oocyte complete maturation and begin its growth after fertilization.  The 
maternal pool of RNA sustains the new embryo until the maternal- embryonic 
transition, at which time the maternally provided RNA declines and the embryo’s 
genome begins to transcribe its own RNA.  The transcription factors controlling 
blastocyst development in the mouse are well studied.   
Maternal pools of cdx2 help polarize blastomeres before the formation of 
the blastocyst (Jedrusik et al., 2010).  In the mouse, embryonic transcription of 
cdx2 appears at 8-cell stage.  At the late morula stage, the cells of the embryo 
begin to sequester into two populations, the TE and ICM.  Cdx2 is gradually 
restricted to, and up-regulated in, the population of cells that will become TE 
(Strumpf et al., 2005).  OCT-4 and Nanog are repressed by cdx2 to the population 
of cells that will become the ICM, allowing TE to differentiate (Berg et al., 2011; 
Masui et al., 2007).  While cdx2 is necessary for the maintenance of self-renewal 
in TE cells, it is not what causes the differentiation of the TE itself (Masui et al., 
2007).  Embryonic transcription of Sox2 becomes active at the morula stage, and 
reaches maximum levels at blastocyst stage (Avilion et al., 2003; Li et al., 2005).   
Maximum Nanog levels occur between the late morula and mid blastocyst 
stage, and then undergoes down regulation just before implantation when Nanog 
becomes restricted to the epiblast in the mouse (Chambers et al., 2003).  The 
blastocyst will then implant into the endometrium and OCT-4 down-regulation 




ICM, cells express Nanog or Gata6 in a salt and pepper pattern by the late 
blastocyst stage, which allows the primitive endoderm to form exclusively from 
the Gata6 expressing cells (Chazaud et al. 2006).  Nanog is necessary to maintain 
the epiblast in embryo, and it represses Gata6, preventing the differentiation of the 
entire ICM into primitive endoderm (Filliers et al., 2011).  
Bovine and human embryos share many similarities throughout early 
development. At day 7 of bovine gestation, the cells of the TE continue to express 
OCT-4, as do the cells within the ICM (Berg et al., 2011).  Nanog and gata6 are 
expressed in ICM cells in salt and pepper pattern, much like the mouse (Filliers et 
al., 2011).  In the bovine, however, the blastocyst undergoes TE expansion and 
gastrulation before attachment, two weeks after the blastocyst is initially formed.  
OCT-4 is expressed in both the TE and ICM cells in the expanded blastocyst 
(Berg et al., 2011).  In the human, OCT-4 mRNA and protein were detected in 
both ICM and TE, with levels in the ICM 31 fold higher than in the TE 
(Cauffman et al., 2006).  Embryonic expression of NANOG was observed with 
the onset of gene activation and morula formation (Kimber et al., 2008).  During 
the expanded blastocyst stage of embryo development, nuclear expression of 
Nanog becomes restricted to a subpopulation of the ICM.   
The domestic cat has more similarities to bovine and human embryo 
developmental models than the mouse.  During in vivo development, domestic cat 
embryos enter the uterine horn between day 6 to 7, during the transition from 
morula to early blastocyst, and attach to the uterus through an endotheliochorial 




bovine, blastocyst implantation in the domestic cat occurs later than in the mouse 
and as such, it is reasonable that the domestic cat blastocyst will show similar 
expression patterns of OCT-4 as the bovine blastocyst, with OCT-4 being 
expressed in both the ICM and TE.   
There have been a few preliminary studies involving mRNA expression 
patterns of early domestic cat embryos.  Initial studies show a loss of mRNA 
during maturation of in vitro oocytes, presumably while maternal pools are used 
up (Waurich et al., 2010).  OCT-4 mRNA has been shown to be detectable from 
germinal vesicle stage oocytes through hatching blastocysts (Filliers et al., 2011).  
OCT-4 does not increase in 8 to 16-cell embryos, but increases seven fold at the 
morula stage (Filliers et al., 2011), and further still during the blastocyst stage 
(Waurich et al., 2010).  OCT-4 protein is localized to the nuclei of ICM and TE 
cells (Gómez et al., 2010).  OCT-4 begins to decrease at the hatching blastocyst 
stage (Filliers et al., 2011).  Cdx2, the TE transcript, is not found at the oocyte 
stage, but is most abundant in hatching blastocysts (Filliers et al., 2011).   
At the 5 to 8-cell embryo stage Sox2 begins to be detectable, and its 
expression continues to increase through to the compact morula stage (Filliers et 
al., 2011).  Sox2 expression was found to be sevenfold higher at the morula stage 
than at the earlier cleavage stages, but expression dropped off during early 
blastocyst stage, and increasing again at hatching (Filliers et al., 2011).  Gata6 
expression is similar to Sox2, at the compact morula stage it is 28-fold higher than 
earlier stages and 3-fold higher than the hatching blastocyst stage (Filliers et al., 




Surprisingly, Nanog is detectable and abundant at all early stages of 
development in the cat, from the germinal vesicle through the 5 to 8 cell stage, 
after which it is down-regulated resulting in levels 23-fold lower in hatching 
blastocysts than MII oocytes (Filliers et al., 2011).  This is contrary to results 
found in the mouse and bovine (Khan et al., 2012), but has some similarity to 
findings in the human.  A maternal pool of NANOG was detected in human 
pronucleate embryos, although not in early cleavage stages.  Embryonic 
transcription of NANOG began at the 8-cell stage in humans (Kimber et al., 2008), 
similar to that observed in ruminants (He et al., 2006) and mice (Chambers et al., 
2003).  A confounding factor that could affect this study is the presence of 
multiple NANOG pseudogenes and newly identified isoforms, all of which may 










Chapter 2: Source of protein supplementation during in 
vitro culture does not affect the quality of resulting 
blastocysts in the domestic cat 
 
This chapter is based on an accepted manuscript by Nestle, E., Graves-Herring, J., 
Keefer, C., and Comizzoli, P. to be published in Reproduction in Domestic 
Animals  
Contents 
The objective of this study was to assess and compare the quality of cat 
blastocysts produced in vitro using commercial blastocyst growth media 
supplemented with different sources of proteins (serum protein substitute from in 
vitro maturation through embryo development vs. 4 mg/ml of bovine serum 
albumin for maturation and 5% fetal bovine serum for fertilization and embryo 
development).  Impact was specifically examined on the proportion of blastocyst 
formation, total number of blastomeres, proportion of ICM and expression of 
pluripotency marker proteins NANOG and OCT-4.  Blastocyst formation per total 
cleaved embryos was similar (P>0.05) regardless of the protein supplementation.  
There were no differences (P>0.05) between culture conditions regarding average 
number of cells and proportion of ICM in each embryo.  Presence of OCT-4 
protein was detected in nuclei of both TE and ICM region, with a stronger signal 
in the latter regardless of the culture medium.  NANOG protein also was present 
in the ICM regardless of the in vitro culture condition.  We, therefore, 




sources for the production of good quality blastocysts and embryonic stem cells.  
In addition, a single defined medium could be successfully used for cat oocyte 
maturation, in vitro fertilization, and embryo development. 
Introduction 
The domestic cat (Felis catus) is an excellent biomedical model as well as 
a good model for rare felid species.  Maintenance of genetic diversity in cat 
populations can be optimized by the use of assisted reproductive techniques 
including the in vitro production and transfer of embryos at the blastocyst stage.  
Studies in the domestic cat also allow the exploration of new technologies taking 
advantage of embryonic stem cells derived from blastocysts (Gómez et al., 2010).  
Both stem cell derivation and embryo transfer necessitate quality blastocysts. 
Blastocyst quality can be assessed using several methods.  Counting the 
total number of blastomeres (the higher the better) as well as the ratio between 
ICM and TE after 7 days of in vitro culture are simple and commonly used 
methods of determining the quality of a blastocyst (Gómez et al., 2010).  In 
addition, levels of NANOG and OCT-4 transcription factors in the ICM of a 
blastocyst can be used to determine blastocyst quality.  Studies in the mouse, rat 
and human have shown that the ICM of a blastocyst can be used to generate 
embryonic stem cells, the pluripotency of these stem cells being reflected by 
levels of NANOG and OCT-4 proteins – two critical transcription factors for the 
maintenance in an undifferentiated stage (Behboodi et al., 2011).  Studies have 
shown that embryos produced in vivo have higher expression of these 




(Behboodi et al. 2011, Roth et al. 1994, du Puy et al. 2011, Yu et al. 2008).  
Therefore, in vitro produced embryos that have high levels of NANOG and OCT-
4 are closer to the in vivo phenotype and thus are considered of higher quality.  
However, when culturing embryos in vitro, the composition of the culture 
medium can significantly affect the quality of produced embryos mainly in terms 
of morphology, metabolism and gene expression.  The quality of the blastocyst 
subsequently influences the success of the implantation, fetal growth, and general 
health of produced offspring (Dobrinsky et al., 1996).   
Studying in vitro production media in various species has revealed that the 
requirements of preimplantation embryos are species and stage specific.  Multiple 
protocols have been developed to generate cat embryos in vitro with varying 
success in blastocyst formation (Waurich et al. 2012).  One interesting study 
sought to make a feline optimized culture medium by identifying precise molar 
concentrations of ions, carbohydrates, amino acids, vitamins and serum necessary 
for early embryonic growth (Herrick et al., 2007).  A commercially available 
defined medium would actually be preferable to better investigate and understand 
the embryo formation in order to standardize embryo culture between 
laboratories. 
Previous studies have examined the importance of protein source when 
culturing embryos of cat and pig in vitro (Dobrinsky et al., 1996; Karja et al., 
2002; Wood et al., 1995) .  Complex biological macromolecules are used in many 
culture systems across species as a source of protein.  However, FBS has been 




allowed more oocytes to be fertilized (Wood et al., 1995).  Interestingly, more 
embryos reach the hatching blastocyst stage and have higher cell number with 
FBS rather than BSA for fertilization and culture (Dobrinsky et al., 1996; Han & 
Niwa, 2003; Herrick et al., 2007; Karja et al., 2002). Contrarily, FBS can diminish 
post-thaw survival following cryopreservation (Murakami et al., 2011; Swanson 
et. al., 1999). 
The objective of this study was to measure the impact of protein 
supplementations (defined vs. semi-defined) on the success of blastocyst 
formation.  The hypothesis was that a defined medium (serum protein substitute) 
could provide blastocysts with high cell number more consistently than a culture 
system that is semi-defined and needs additional protein supplementation (i.e., 
FBS and/or BSA). 
Materials and Methods 
Oocyte maturation and embryo production 
Oocyte selection and main steps of the in vitro culture were performed using 
standard protocols developed in our laboratory (Waurich et al., 2012; Wood et al., 
1995).  Briefly, ovaries were obtained from local veterinary clinics and stored in 
PBS (Gibco) at 4°C for up to 24 hours.  Immature cat oocytes (n = 2126 total; 29 
replicates) were collected from adult ovaries and matured in 50 µl droplets of 
Medium A (Sage) or B (Irvine) supplemented with 0.01% (v/v) FSH, 0.01% LH , 
0.16% E2 (Hormones: National Hormone and Pituitary Program (NHPP)) and 4% 




essentially the same salt composition and components with the exception of 
protein source.  In Medium A, the serum protein substitute contained 88% normal 
human serum albumin in the presence of 12% α and β globulins.  After 26 to 28 
hours of maturation, oocytes were fertilized with 5.0 x 105 motile sperm ml-1 of 
frozen-thawed epididymal spermatozoa from different males.  Oocytes and sperm 
cells were co-incubated for 16 to 18 hours.  A control for parthenogenesis (no 
sperm cell insemination) was included in each replicate.  Presumptive zygotes 
were then cultured in vitro and media was changed at day 4.  For in vitro 
fertilization and embryo culture, Medium B was supplemented with 5% FBS 
(Irvine Scientific) whereas Medium A contained the same protein substitute.  
After 7 days of embryo development in vitro, proportions of different embryo 
stages were recorded according to previous criteria (Wood et al., 1995). 
Immunocytochemistry 
Immunostaining was done at 38°C unless otherwise noted.  Day 7 blastocysts 
were fixed in 5% paraformaldehyde (FisherBioTech) in PBS for 30 min.  
Following fixation, embryos were washed in saturation medium (20% FBS, + 
0.5% Triton-X100 (TX100, Sigma-Aldrich) in PBS) for 5 min, then blocked in 
saturation medium for 30 min before being incubated with a primary antibody 
(anti-OCT-4 (Millipore, No. MAB4401), 1:200; or anti-NANOG (AbCam 
#ab80892), 1:200) at 4°C overnight.  The following morning embryos were 
washed in medium (2% FBS + 0.5% TX100 in PBS) for 45 min before being 
incubated with the secondary antibody (FITC (Sigma-Aldrich,  No. F2266) 1:100 




Chromatin was stained using 10µg/ml Hoechst 33342 (Sigma-Aldrich) and 
5µg/ml propidium iodide (Sigma-Aldrich) for 10 min.  Stained embryos were 
mounted in Vectashield® (Vector Laboratories) on a glass slide, sealed with nail 
polish, and stored at 4°C. 
qRT-PCR 
A pool of 5 blastocysts at day 7 post insemination were suspended in lysis buffer 
(Buffer RLT, RNeasy Protect Micro Procedure Kit, Qiagen) and were snap frozen 
at -80°C for less than 6 months until processing.  Total mRNA was isolated using 
an RNeasy Protect Micro Procedure Kit (Qiagen) according to the manufacturer’s 
directions.  Concentration of mRNA was determined using Nanodrop, and cDNA 
was produced using a Quantitect RT Kit (Qiagen) according to manufacturer’s 
directions. Quantitative real time PCR (qRT-PCR) was then performed on a 
BioRad thermocycler using iQ-SYBRGreen Supermix (BioRad) following 
manufacturer’s instructions and using the primers provided in Table 1.   
Experimental design and statistical analysis 
Domestic cat ovaries were recovered from local veterinary clinics during routine 
spay procedures. On a given day, recovered oocytes were evenly distributed 
between the two culture media.  Resulting blastocysts (OCT-4, 4 replicates: 
Medium A, n =12, Medium B, n=18; NANOG, 5 replicates: Medium A, n=27, 
Medium B, n=11) were fixed and immunostained for the pluripotency proteins 
OCT-4 and NANOG (and determination of number of cells in the ICM).  











Table 1: Primers for qRT-PCR: The gene name, forward and reverse primers, 
amplicon size and annealing temperature are provided. Citations are provided for 
the original design of these primers.  Primers were obtained from Integrated DNA 
Technologies. The sequence of gene products was confirmed after purification. 
 
Gene Sequence Size (bp) Citation 
Annealing 
Temp 
NANOG F: CCTGAACATACAGCCTGAAGTC 113 Gomez 2010 58.86 
  R: AAGGCAGAGATAGAGGACCCTA     59.77 
SOX2 F: CATCACCCGCAGCAAATGA 111 Gomez 2010 59.72 
  R: AAGAAGTCCAGGATCTCTCATAAA     60.36 
OCT-4 F: TGCAGCTCAGTTTCAAGAACA 112 Gomez 2010 59.77 
  R: ACAAGTGTCTCTGCTTTGCATA     57.72 
RPL-17 F: CTCTGGTCATTGAGCACATCC 109 Penning 2007 60.27 




gene expression analysis.  The remaining non-blastocyst embryos were stained for 
chromatin using 10µg/ml Hoechst 33342 and 5µg/ml propidium iodide for 10 min 
to evaluate embryo stage. The rate of cleavage was recorded as well as the 
percentage of blastocysts produced from total oocytes fertilized. Cell numbers 
were analyzed using an unpaired T-test.  Proportions of cleaved cells reaching 8 
cells, 8 to 16 cells, morula, and blastocyst stages were transformed (arcsin) and 
analyzed using an unpaired two-tailed T-test (Graphpad Prism 5, GraphPad 
Software, Inc).  The ΔCt method and ANOVA was used to analyze the relative 




Embryonic cleavage  
The percentages of cleaved embryos obtained with the two media were not 
different (P > 0.05; Table 2).  Parthenogenetic activation was not observed in 
either culture medium.  The proportions of each embryo stage including 
blastocyst formation were also similar (P > 0.05) between the two media (Table 
2).  A small proportion of blastocysts (~5%) were hatched after 7 days of culture 
regardless of the medium.  There was no significant difference in the number of 
hatched blastocysts produced in either media (Fisher’s Exact Test). 
There were no differences (P > 0.05) between media regarding average 











 Table 2: Percentages of cleaved embryos and proportions of each developmental 
stage obtained after in vitro culture in the two different media:  Values are 
expressed as mean ± SE. Numbers within columns with the same letter were not 








% Cleaved Proportion of embryo stages (per total cleaved) 
   <8-cells  8 to 16 cells  Morula Blastocysts 
A 1062  74.1 ± 2.0a 24.6 ± 2.3 a 24.9 ± 2.7 a 20.9 ± 2.6 a 29.6 ± 3.8 a 




10.2) and proportion of ICM in each embryo (Medium A: 23.7% ± 2.0; Medium 
B: 24.7% ± 1.5) as represented in Figure 7. There was no difference in the 
variance of any cleavage state (F-test). 
Immunostaining for pluripotency marker proteins 
Immunostaining revealed the presence of OCT-4 protein in nuclei of both 
TE and ICM region, with a stronger signal in the latter (Figure 8B) regardless of 
the culture medium. NANOG protein also was detected in the ICM (Figure 8E) of 
embryos from both media. 
Analysis of pluripotency marker genes via qRT-PCR 
OCT-4 and SOX2 mRNA was observed in the nuclei of cells of the ICM 
and TE in embryos produced using both media. There was no significant 
difference between the two media for any gene (P > 0.05). SOX2 had the smallest 
relative difference between the two media, while OCT-4 had the largest.  No trend 
could be detected between the two media.  Results of individual trials are 
provided in Figure 9 to demonstrate the range of values obtained per embryo pool.  
There was no significant difference between the average of the three trials for 
either media for any gene (P > 0.05, ANOVA, Figure 10).   
Discussion 
 The quality of an in vitro produced blastocyst can be defined by the total number 
of cells and the presence of pluripotency proteins NANOG, SOX2 and OCT-4.  In 
this study, we found no difference between media and protein sources for the 







Figure 7: Individual blastocyst analysis: Proportion of total cells that occurs in the 
ICM per blastocyst per medium is shown in A. Cell number is compared per 













Figure 8: Immunostaining of OCT-4 (B) and NANOG (E): Propidium Iodide 
staining to show blastomere nuclei (A, D). OCT-4 protein (B). Images C and F 










Figure 9: Expression values for Individual Pooled Samples of NANOG, OCT-4, 
and SOX2 in blastocysts following in vitro culture:  ΔCt values of NANOG, 
OCT-4 and SOX2 mRNA in individual pools of 5 domestic cat embryos each. 
A1-A3 denotes experimental replicates for embryos cultured in Medium A, 
whereas, B1-B3 represent those cultured in Medium B. Cat fetal fibroblasts (CFF) 
were run as a negative control. Expression was normalized to the house-keeping 
gene, RPL-17. 
 
Figure 10: Average expression of NANOG, OCT-4 and SOX2 in blastocysts after 
in vitro culture in the two different media (number of pools=3):  A represents the 
average of three trials of medium A, and B represents the average of three trials of 
medium B.  Expression was normalized to the house-keeping gene, RPL-17.  






































Expression of NANOG, OCT‐4, and SOX2  in 
blastocysts following in vitro culture: Values for 






















Average expression of NANOG, OCT-4 and SOX2 in 








proportion of cells in the ICM between media and protein sources either.  
Concordantly, expression of the pluripotency proteins NANOG and OCT-4 was 
similar between the two culture conditions.  We also found that the proportion of 
cleaved embryos for either medium was not significantly different. The cleavage  
proportions for each embryo stage (less than 8-cells, 8 to 16 cells, morula, and 
blastocyst) were similar between the two media.  Both the rates of cleavage and 
proportion of embryos to reach the blastocyst stage were comparable to similar 
studies in the cat (Gómez et al., 2010).  Depending on the expertise and selectivity 
of the scientist, in vitro fertilization success rates can be as high as 70 to 80% with 
nearly 80% of embryos reaching morula stage by 96 hours post insemination 
(Roth et al., 1994).  A typical day 7 cat blastocyst should have at least 100 to 150 
cells (Pope et al., 2006; Spindler & Wildt, 2002). 
Both media produced good quality blastocysts of high cell number that 
expressed NANOG and OCT-4 proteins.  Our results confirmed that in a 
blastocyst, OCT-4 protein was present in the nuclei of both the TE and ICM; 
however, it was more prominently in the ICM.  NANOG protein was found to be 
present in the ICM only.  NANOG and OCT-4 mRNA were found to be present at 
comparable levels in blastocysts grown in both media.  There was no significant 
difference between the relative expression of the genes between the two media.  
Thus, cat blastocysts expressed pluripotency proteins in a pattern similar to the 
bovine model (Berg et al., 2011), porcine model (Kirchhof et al., 2000) as well as 




Protein source in culture media has been shown to have a critical effect on 
the maturation of oocytes and success of blastocyst formation. Previous studies 
have shown that BSA is best used for oocyte maturation, followed by FBS for 
fertilization and culture to the blastocyst stage, resulting in more hatched 
blastocysts with higher cell number comparatively (Dobrinsky et al., 1996; Han & 
Niwa, 2003; Herrick et al., 2007; Karja et al., 2002; Wood et al., 1995).  The 
media used in this study had the same components and salt composition, with the 
exception of protein source. In Medium A, the serum protein substitute contains 
88% normal human serum albumin with 12% α and β globulins. The high content 
of polyhydroxy domains in the α and β globulins produces a weak gel-like 
environment that can enhance embryonic development both in human and mouse 
embryos (Weathersbee et al. 1995).  The serum albumin protein sequences for 
human and cat are more similar than for cat and bovine, (H:C 82%; B:C 78%); 
however, there was no beneficial effect of using human serum over bovine.  To 
the author’s knowledge, this is the first time human serum (present in the serum 
protein substitute) has been used successfully for cat embryo culture.  
Interestingly, the medium containing serum protein substitute performed equally 
well as the media that used BSA for maturation and FBS for fertilization and 
culture.  Using the same protein source from in vitro maturation through embryo 
culture did not influence the quality of the resulting blastocysts.  
This study demonstrates that high quality blastocysts can be culture in 
vitro for the domestic cat utilizing two commercially available media.  Producing 




starting material for performing embryo transfer, derivation of embryonic stem 
cells, and for additional research.  Further advancement in the understanding of 
the nutritional requirements of preimplantation embryos will enable improved 
media to be developed and generation of blastocysts that may more closely 




Chapter 3: Comparison of cytokine supplementation on 
ICM explant growth  
 
Contents 
The objective of this study was to assess and compare the maintenance of 
pluripotency markers OCT-4 and NANOG in inner cell mass (ICM) explants 
from in vitro produced blastocysts over a period of 14 days.  ICM explants were 
cultured using a combination of 3 inhibitors (3i: CHIR99021, PD173074, 
PD0325901), mouse LIF and BMP4, or mouse LIF and human recombinant 
bFGF.  Explants were imaged with bright field (day 7 and day 14), 
immunostained for OCT-4 and NANOG (day 14), and samples were analyzed for 
gene expression using qRT-PCR (day 14).  There was no statistical difference 
between the three conditions for the expression of OCT-4 or SOX2, for the 
number of persisting explants on day 14, or between the numbers of large or small 
colonies between the three conditions. 
Introduction 
Embryonic stem cells (ESCs) hold much promise for therapeutic research.  
While stem cells have been a topic of research for over three decades, naïve ESCs 
have been produced and validated only in the mouse and rat.  Authenticated naïve 
ESCs are defined by several characteristics: unlimited self-renewal, rounded 
colony morphology, expression of specific molecular markers, maintenance of 
normal karyotype, and the ability to differentiate into any cell type in the body.  




species requires specific research to define the best culture conditions to derive 
and maintain embryonic stem-like cells, eventually leading to truly naïve ESCs.  
Naïve ESCs can be incorporated into a blastocyst producing chimeric offspring, 
useful for biomedical and genetic studies. Naïve ESCs can be differentiated into 
gametes, demonstrating a potential avenue for preserving genetic material for rare 
genomes such as endangered felids (Kerkis et al., 2007). 
A common starting point for deriving ESC lines from novel species is 
based on knowledge gained from mESCs.  A typical culture cocktail for the 
mouse contains LIF and BMP4 (Ying et al., 2003).  LIF acts to promote self-
renewal by activating the STAT3 pathway and BMP4 induces expression in the 
SMAD pathway leading to inhibition of differentiation (Ying et al., 2003).  
Alternative cytokines are added to the media as successes and failures are 
observed in nonmurine species.  Each change in cytokines reveals potential active 
and inactive pathways of pluripotency in these novel species.  The first attempt at 
deriving stem cells for the domestic cat used LIF in the culture medium (Yu et al., 
2008), soon after, a combination of LIF and human basic fibroblast growth factor 
(b-FGF) (Gómez et al., 2010) was used, producing ES-like cells that could 
survive longer in culture than those produced by Yu et. al. 2008. bFGF serves to 
maintain self-renewal as well as promoting ERK and PI-3K pathways (Honda et 
al., 2009) and is typical of what is described for EpiSC. 
At the time of writing, no validated embryonic stem cell exists for the 
domestic cat, although several attempts have been made.  Yu et al (2008) used in 




passages, determining that medium containing KSR allowed ICM cells to attach 
better and form domed colonies, while medium containing FBS formed flat 
colonies and with higher cell proliferation.  Gómez et al., (2010) generated and 
maintained ES-like cells derived from in vitro produced domestic cat blastocysts 
for up to 12 passages (102 days). Gómez et al., (2010) found that their ICM 
explanted colonies produced had a tightly packed, dome shaped morphology, 
alkaline phosphatase activity, and readily expressed OCT-4, SSEA-1, NANOG, 
SOX2 and C-MYC, although expression levels of colonies were at a lower level 
than blastocysts.  Several studies have verified that cat ES-like cells seem to 
survive undifferentiated and proliferate longer when grown on a homologous 
layer of blocked cat fibroblast cells (Gómez et al., 2010; Serrano et al., 2005; Yu 
et al., 2008).  While typically in vivo produced embryos have more developmental 
competence than in vitro produced embryos (Bavister, 2004), in vitro embryos are 
much easier to obtain for many species, including the domestic cat.  In earlier 
studies (Chapter 2), we showed that good quality cat embryos could be produced 
in vitro using a defined protein supplement.  
In this study, we compared the use of LIF + BMP4 (mouse condition), LIF 
+ bFGF (cat condition), and a combination of inhibitory molecules that has shown 
success in induced pluripotent and embryonic stem cells (3i condition) (Buehr et 
al., 2008; Gómez et al., 2010; Telugu et al., 2010; Ying et al., 2003).  We 
examined the effect of these different cytokine conditions on the growth of ICM 




that provides superior conditions for deriving cat ES-like cells and maintaining 
pluripotency in future studies.    
We predicted that the cocktail of inhibitory small molecules would 
provide a superior environment for maintenance of “stemness” in cat ICM explant 
cells due to the small molecules having fewer species-specific characteristics.  As 
such, they should overcome any species-specific cytokine receptor differences in 
pluripotency promoting pathways, and stimulate specific pluripotency pathways 
and the inhibition of differentiation in domestic cat explant cells.  Due to 
differences between mouse and cat pluripotency promoting pathways, we 
predicted that the current domestic cat ES-like cocktail condition would be 
superior to the current cytokine cocktail used in rodent ESC culture.  These 
predictions proved false as demonstrated by the failure of ICM explants to thrive 
under 3i conditions. 
Materials and Methods 
Generating and blocking cat fetal fibroblast cells 
Primary cat fetal fibroblasts (CFF) were generated from 3 fetuses obtained as 
waste tissue from one gravid female cat approximately 35 days of gestation after 
hysterectomy for non-research related reasons.  The uterine horns were extracted, 
placed in a Petri dish and rinsed with PBS.  Fetuses were excised from the 
embryonic sacs, rinsed thoroughly and fetal visceral tissue was removed.  
Remaining tissue was cut into small pieces and incubated with Trypsin in 5% 
CO2 at 37°C for 20 minutes with shaking.  The cells were centrifuged for 




Glasgow Minimal Eagles Medium (GMEM, Gibco) supplemented with 10% fetal 
bovine serum (FBS), 2.4 mM L-glutamine (Gibco), 2.4 mM sodium pyruvate 
(Gibco), 2.2 mL Dulbecco’s Modified Eagles Medium (DMEM, Gibco), 10 U/mL 
penicillin, 10 g/mL streptomycin in 75cm2 flasks for 7 to 10 days of culture at 
38°C in 5%CO2.  After 7 to 10 days, monolayers were disaggregated with 
2.5mg/mL of trypsin, resuspended in DMEM (Gibco) supplemented 5% DMSO 
(FisherBioTech).  Cells were cooled at 1.0°C .min to -80°C  (Mr. Frosty; 
Nalgene) and stored in liquid nitrogen.  
As needed, CFFs were thawed and blocked following the protocol 
provided in Gomez et al. 2010.  Briefly, cells were thawed from liquid nitrogen, 
washed, and expanded for at least 3 days in culture.  Medium was removed from 
the culture dishes and 40µg/mL of mitomycin-C (MMC, Sigma-Aldrich) was 
added for 4 to 5 hours at 37°C at 5% CO2.  MMC was removed and trypsin was 
added for 2 to 3 minutes at 37°C at 5% CO2.  Cells were rinsed with PBS at least 
3 times before being plated on a gelatin coated 4-well plates.  Cells were 
maintained in GMEM and could be used after 2 hours and within 3 days of being 
blocked. 
Aliquots were thawed as needed in 37°C dry baths and swirled gently until 
thawed.  To count total cells, 10µl of cells and 90µl of Trypan Blue were mixed 
and cells were counted using a hemocytometer.  A final concentration of 1x105 
cells/well (24 well) was added to each gelatin coated well.  Plated cultures were 




medium was replaced with medium based on Gomez et al. (2010) on the day of 
plating ICMs. 
Explantation of inner cell masses and passaging of cells after explantation 
Embryos were produced using the protocol laid out in Chapter 2.  Day 6 
blastocysts were preincubated in the media cocktail for 24 hours at 38.5°C and 
5% CO2.  Mechanical dissection was performed using two 30 gauge needles.  The 
zona pellucida was removed and the embryo was laid out in a single layer.  The 
ICM was removed from the TE and plated separately with as little TE as possible.  
Cells were cultured at 38.5°C in 5% mixed gas.  Brightfield images were taken at 
D0.  Media was changed every 1 to 2 days.  After 7 days of culture, brightfield 
images were taken and culture continued.  At 14 days of culture, brightfield 
images were taken before large colonies were split into 2 to 3 pieces.  The first 
piece was fixed for immunostaining for OCT-4 and NANOG, the second piece 
was stored in lysis buffer for qRT-PCR analysis and if a third piece could be 
obtained, it was explanted onto fresh blocked CFFs and culture continued.  Small 
colonies (those that were less than 300 µm) were trypsinized with the CFFs in 
each well (producing a whole well lysate) and stored in lysis buffer for qRT-PCR 
analysis. 
 
Preparing cytokine cocktails 
Explants were placed into wells containing 1mL of base embryonic stem-like cell 




Serum replacement (Invitrogen), 5% FBS (Irvine Scientific), 1mM L-glutamine 
(Gibco), 0.1mM B-mercaptoethanol, 1.25% non-essential amino acids, 50 
Units/mL penicillin and 50ug/mL streptomycin (Gómez et al., 2010). The mouse 
condition was prepared by the addition of 1000 Units/mL of mouse LIF (Esgro, 
Chemicon / Millipore) and 8ng/mL mouse BMP4 (R&D Systems).  The cat 
condition was prepared by the addition of 1000 Units/mL of mouse LIF and 
5ng/mL human recombinant bFGF (Peprotech). The 3i medium was prepared by 
the addition of 3µM CHIR99021 (Stemgent), 1µM PD0325901 (Stemgent), and 
0.1 µM PD173074 (Stemgent) (Table 3). 
Immunocytochemistry 
Immunostaining was done at 38°C unless otherwise noted.  Day 14 ICM explants 
were fixed in 5% paraformaldehyde in PBS for 30 min.  Following fixation, 
explants were washed in saturation medium (20% FBS, + 0.5%Triton X100 in 
PBS) for 5 min, then blocked in saturation medium for 30 min before being 
incubated with a primary antibody (anti-OCT-4, 1:200, Millipore, No. MAB4401; 
or anti-NANOG, 1:200, Abcam, No. ab80892) at 4°C overnight.  The following 
morning explants were washed in medium (2% FBS + 0.5% TX100 in PBS) for 
45 min before being incubated with the secondary antibody (FITC, 1:100, Sigma, 
No. F2266; in washing medium) for 1 hour.  A 30 min rinse in washing medium 
followed. Chromatin was stained using 10µg/mL Hoechst 33342 and 5µg/mL 
propidium iodide for 10 min.  Stained explants were mounted on a glass slide, 
















Table 3: Three cytokine treatments: Small molecules (3i), the currently used 
cytokine combination for domestic cat ES-like cells, and a currently used cytokine 
combination used for mouse and rat ESC.  The small molecule and rodent-like 
culture conditions are hypothesized to produce naïve ES-like cells from the cat, as 
has been shown in the mouse.  Condition B, the cat ES-like culture condition, 
should produce EpiSC, due to the inclusion of FGF. 
 
A: Naïve - Small Molecule Inhibits 
PD173074 0.1µM FGF 
PD0325901 1µM ERK 
CHIR99021 3 µM GSKB3 
KSR/Feeder Layer 
  
B: Control – Cytokines for cat ES-like culture (Gómez et al., 2010) 
LIF 1000 U/mL  Activates Jak/Stat, MAPK  
bFGF 5ng/mL 




C: Naïve – Cytokines for rodent ESC culture  (Ying et al., 2003) 
LIF 1000 U/mL  Activates Jak/Stat, MAPK 








Large colonies were divided into 2 to 3 pieces, one of which was stored in lysis 
buffer for genetic analysis at day 14 post explantation.  Small colonies and CFF 
control wells were trypsinized as whole wells and stored in lysis buffer at day 14 
post-explantation as follows.  Trypsin was added to wells for 2 to 3minutes at 
37°C in 5% CO2.  Cells were centrifuged for 3 min at 1000RPM, the supernatant 
was removed and pellet resuspended with PBS.  Cells were centrifuged again and 
supernatant removed.  Cells were then resuspended in lysis buffer (Buffer RLT, 
RNeasy Protect Mini Procedure Kit, Qiagen,  No.74124) and were snap frozen at 
-80°C and stored for less than 6 months until processing. Total mRNA was 
isolated using an RNeasy Protect Micro Procedure Kit according to the 
manufacturer’s directions.  Concentration of mRNA was determined using 
Nanodrop, and cDNA was produced using a Quantitect RT Kit according to 
manufacturer’s directions. Equal amounts of cDNA were analyzed by quantitative 
PCR performed on a Biorad thermocycler using iQ-SYBRGreen Supermix 
following manufacturer’s instructions and using the primers provided in Table 4. 
 
Experimental design and Statistical analysis 
Domestic cat embryos were cultured using Quinn’s Advantage Protein Plus 
medium (Sage) for 7 days, as described in Chapter 2.  Five oocytes were not 
fertilized during each trial to observe for parthenogenetic activation.  At day 6, 
blastocysts and morula were evenly distributed and preincubated in each of the 













Table 4: Primers for qRT-PCR: The gene name, forward and reverse sequence, 
amplicon size and annealing temperature are provided.  Primers were obtained 
from Integrated DNA Technologies and designed based on the cat genome . The 
sequence of gene products was confirmed after purification. 
 
Gene Sequences (5'-3') Size (bp) Annealing Temp (°C) 
OCT-4 F: TGACTATTCGCAACGAGAGG 121 59.02 
  R: GAAGTGAGGGCTTCCATAGC   58.89 
NANOG F: GAAGAAGGACGATCCAGCTC 127 58.97 
  R: TTCTTGCATCTGCTGGAGAC   59.12 
SOX2 F: ATGCACAACTCGGAGATCAG 130 58.83 
  R: TATAATCCGGGTGCTCCTTC   59.00 
RPL-17 F: AATGCGGCGTAGAACTTACA 125 58.47 





portable incubator at 38ºC from the Smithsonian National Zoological Park to the 
University of Maryland, College Park, where the ICM was subsequently 
mechanically dissected away from the TE and tacked down onto a homologous 
feeder layer.  Feeder cells were thawed and blocked at least 24 hours in advance 
of use, and plated into 4 well dishes.  At least three explants were placed onto the 
cat fetal fibroblast feeder layer in the wells of a 4 well dish, under 1mL of the 
appropriate cytokine conditions.  Five additional wells of CFF monolayer were 
prepared, one well each of the base medium containing each cytokine condition, 
the base medium with no cytokines, and a basic cell growth medium (DMEM plus 
10% FBS, 1% Pen/strep, 1% L-glutamine) as negative controls.  Media was 
changed every 1 to 2 days for 14 days.  On day 7, brightfield images were taken 
and colony number was assessed.  On day 14, brightfield images were taken, 
colony number assessed, and any large colonies were split into 2 to 3 pieces.  
Large colonies are defined as greater than 300µm, (small colonies were generally 
~100µm in diameter and assumed to be non-growing).  One piece of the large 
colony was stored in lysis buffer for gene analysis for OCT-4, SOX2, NANOG, 
and RPL-17 via qRT-PCR, one piece was immunostained for OCT-4 and 
NANOG proteins, and the final piece (if available) was replated on a fresh feeder 
layer to observe further growth.  The remaining non-blastocyst embryos were 
stained with propidium iodide or Hoechst 33342 to evaluate embryo stage.  The 
rate of cleavage was recorded as well as the percentage of blastocysts produced 




cells, morula, blastocyst, and hatching blastocyst were recorded to ensure that all 
trials were similar.  
The number of colonies produced between the three conditions was 
analyzed using an unpaired t-test.  Any differences in morphology were noted 
throughout growth.  The RNA expression level of pluripotency markers (NANOG, 
OCT-4, and SOX2) and one reference gene were measured in triplicate using 
qRT-PCR and results were normalized to the reference gene.  qRT-PCR results 
were analyzed using the Livak (ΔΔCt) Method, with partly enriched cat 
spermatagonium stem cells (SSC) used as the comparator, and ΔΔCt values 
compared using ANOVA. 
Results 
Fertilization and cleavage rates of blastocysts 
Parthenogenetic activation was not observed during the duration of this 
experiment.  Blastocyst rates were comparable to study 1 and the literature 
(Gómez et al., 2010; Yu et al., 2008).  Nearly half of fertilized oocytes became 
blastocysts by 7 days post fertilization and almost 20% of these began hatching by 
the time of explantation (Table 5).  This increase in the number of fertilized 
oocytes reaching the blastocyst stage was likely due to an increased selection of 
higher-grade oocytes. 
Explant Growth 
 For each growth trial, at least three blastocysts were mechanically 






















Table 5: Percentages of cleaved embryos and proportions of each developmental 














<8-cells 8 to 16 cells Morula Blastocyst 







not be completely separated from the ICM region.  Early blastocysts or those with 
ICM regions that could not be visualized were dissected into a monolayer and 
plated as such.  No condition had a significant difference in the number of 
explants that survived to D7 post explantation (P>0.05, Table 6).  There was no 
significant difference between the numbers of explants that persisted to D14 
between the treatments (P>0.05, Table 6).  The cat cytokine condition had 52% of 
explants persisting at D14, while the mouse had 51% and 3i had 46.5%.  There 
was no significant difference between treatments in the number of small or large 
colonies (P>0.05, Table 7).  Of the total number of ICM regions explanted, 7 
(15.5%) of the mouse colonies grew to a large size (at least 300µm in diameter), 
while the cat had 3 (7%) and the 3i condition had 1 (2%). Proportion of ICM 
explants considered to be large was not significantly different between groups 
owing to the small sample sizes. Explant morphology was documented by 
brightfield imaging conducted at D7 and D14 post explantation for every 
persisting explant (Figure 11). 
Immunostaining and qRT-PCR 
Most of the large colonies had a TE like appearance with occasional 
smaller tightly packed cells.  The TE like cells stained positively for OCT-4 
(Figure 12A-C).  Immunostaining was only performed on portions of large 


















Table 6: Description of explants:  The number of explanted colonies on day 0, day 
7, and day 14 were determined under brightfield using a Leica DML inverted 















Mouse 45 29 23 51.1%a 
Cat 42 25 22 52.3% a 









Table 7: Comparison of colony size: The percentage of colonies smaller or larger 














Mouse 16 7 30.4% a 
Cat 19 3 13.6% a 








Figure 11: Brightfield imagery: Original ICM explants (day 0) are small, less than 
100µm (A). A small colony at day 14 of culture is similar in size to an original 
explant (B), whereas a large colony at day 14 of culture is greater than 300µm in 














Figure 12: Immunostaining for OCT-4 protein: Brightfield images are shown in A 
and D. OCT-4 staining is shown in B and E.  Hoechst 33342 staining for nuclear 
material is shown in C and F.  Only colonies over 300µm were considered large. 
Many of these colonies had a TE-like appearance (A-C).  Small colony shown in 
E and D had ESC-like morphology (small, round, tight edged colonies, intense 
nuclear OCT-4 staining). 
 
  




 Results for analysis of mRNA for OCT-4 and SOX2 are shown in Figure 13.  
Genes were normalized to the house-keeping gene RPL-17 and the Livak (ΔΔ Ct) 
method was used to analyze the fold difference of genes using domestic cat 
enriched spermatogonial stem cells (SSC) as the comparator. Results obtained 
from the three trials had large standard deviations. OCT-4 was present in the cat 
condition (LIF + bFGF) only, both in the ESC lysate and the whole-well lysate 
(which includes feeder cells and possible small explant colonies).  Surprisingly, 
the whole well lysate had a high level of OCT-4. This could be due to the 
presence of several small explants or remnants of large explants after their 
removal.  SOX2 was found in all conditions, although no significant difference 
was seen in the fold difference between cytokine conditions when normalized to 
RPL-17 and SSC cells (P>0.05).  NANOG was not analyzed due to contamination 
issues that affected only runs for that gene.    
Discussion 
There was no significant difference between embryo growth trials. The 
blastocysts produced using this culture techniques have been previously checked 
for the production of pluripotency markers using immunocytochemistry and qRT-
PCR (Nestle et al., 2012).  The rates of blastocyst formation obtained were 
comparable to the literature and better than during the media trial (Chapter 2; 
Gómez et al., 2010; Yu et. al., 2008).  Hatching and late staged blastocysts were 
preferentially used for isolation of ICM explants.  The increased rate of blastocyst 




For the cytokine treatments, our hypothesis was that the 3i condition would 




Figure 13: Results of qRT-PCR in ICM explants:  OCT-4 expression is shown in 
A and B. SOX2 is shown in C and D. Each cytokine condition had a sample of cat 
fetal fibroblast (CFF) cells to confirm that the cytokine condition did not alter 
gene expression in the feeder cells. The explant columns for cat and mouse in A 
and C represent the results of analysis of the portions of large colonies removed 
from the remaining CFFs and potential small colonies, conversely, B and D 
represent results from an entire well lysate containing all cell types combined. 
The one large colonies from the 3i condition was not analyzed. Bars represent 
standard deviation (n=3 trials), no significant differences between values were 
determined by ANOVA. 
 
 
A      B 
Expression of OCT-4 in ICM samples Expression of OCT-4 in ICM wells 
 
C      D 






the worst. Surprisingly, the cat cytokine condition had 52% of colonies persisting 
at D14, while the mouse had 51% and 3i had 46.5%, with no significant 
difference between treatments in the number of small verses large colonies (Table 
7).  The mouse condition had 15.5% of colonies grow to a large size (at least 
300µm in diameter), while the cat had 7% and the 3i condition had 2%.  No 
condition was significantly better based on colony counts, due to the limited 
numbers available. 
Immunostaining was only performed on portions of large colonies.  OCT-
4 was found to be present in both the tightly packed ES-like explant cells as well 
as the cells that had TE morphology (Figure 9).  The tightly packed colonies were 
difficult to see with bright field; unlike mESC colonies, which can be easily 
visualized with brightfield imaging.  Due to the removal of colony portions from 
large colonies for immunostaining, only a limited number of samples were 
available for qRT-PCR.  In the future, larger more homogenous colonies will be 
needed to generate enough cells for simultaneous confirmation of protein and 
mRNA expression. 
OCT-4 protein and mRNA were present in explants from the cat and 
mouse conditions.  When larger explants were removed and analyzed separately 
from the rest of the culture well, we saw expression of OCT-4 mRNA in the 
whole culture well sample; however, we did not see OCT-4 mRNA present in the 
CFF samples.  This suggests that some smaller explant colonies or remnants of 




mRNA was present in all conditions and the feeder cell control wells. A more 
complete picture could be obtained by immunostaining for SOX2 protein as well.  
We were unable to determine whether or not NANOG was present in the 
explants due to contamination issues that affected only runs for that gene.   It is 
unlikely that substantial NANOG was expressed in the explants due to the mostly 
TE like morphology, and poor results following immunostaining.  NANOG is 
essential for the maintenance of pluripotency and should be evident, if the cells 
were indeed ES-like cells. 
While we predicted that the 3i condition would perform the best, our 
results show that it did not provide the best conditions for growth.  The 3i 
condition is specifically designed to restrict pathways that lead to differentiation 
or a lack of self-renewal, similar to the naïve condition, however if the explants 
were more similar to EpiSC, then the 3i cocktail would not allow their growth.  
For example, the addition of PD0325901 to inhibit MEK (via ERK) should block 
any EpiSC from developing because of their dependence on FGF/ERK signaling 
(Buehr et al., 2008).  In the future, addition of LIF to the 3i condition may 
produce different results.  Adding LIF to a 3i cocktail has been shown to have 
some success for porcine (Telugu et. al, 2010).  It has been reported that 
CHIR99021 may delay chromosome alignment and induce instability in 
chromosomes in cultured HeLa cells (Tighe et. al., 2007).  If the compound has 
the same effect on cat ESCs, other factors may need to be tested to disrupt the 




supplementation has shown success in maintaining induced pluripotent stem cells 
and may still hold promise for the domestic cat. 
All three conditions produced at least one large colony that persisted to 
day 14.  All large colonies had either a TE like appearance or a combination of 
TE and an ESC-like colony appearance.  All colonies stained similarly for OCT-4 
protein; the protein was localized to the nuclei of cells and was more intense in 
the ES-like small colonies, rather than the TE like colonies.  
While significance was not obtained for any of our parameters, the mouse 
condition (BMP4 and LIF) produced colonies that were large in size, while 
simultaneously having high levels of mRNA for OCT-4 and SOX2 proteins.  Also 
a small region containing tightly packed cells, which stained intensely for nuclear-
localized OCT-4 was observed. Surprisingly, the trend in regards to number of 
colonies established was the opposite of that predicted with mouse and cat 
conditions being greater than 3i, however, due to low efficiencies of colony 
formation, these differences were not significant.  For future experiments the 3i 
conditions should be altered with the goal of improving explant survival and 
growth.  This project has helped to elucidate some of the pathways that may be 
active in maintaining pluripotency in the cat as well as showing that these 






Chapter 4: Discussion 
 Embryonic stem cells are a dynamic population that can be manipulated 
and directed to become any cell type found in the body.  Providing conditions, 
which would allow these cells to maintain pluripotency, has proven to be difficult 
in species other than the mouse, rat and human.  The competency of the starting 
material determines the initial success of the derived embryonic stem cells, as 
well as the supporting media they are cultured in.  Producing high quality 
blastocysts that express the pluripotency markers is essential to the derivation and 
maintenance of these novel cell lines.  In these studies, we have demonstrated that 
a defined medium can support development of good quality blastocysts, which 
express NANOG, OCT-4 and SOX2.  Furthermore, we assessed the ability of 
resulting ICM explants to maintain expression of these pluripotency makers using 
three different cocktails of cytokines or small molecules.  
Domestic cat embryos have been cultured for decades and yet the rates of 
blastocyst formation are still below that of the mouse.  Culture media have ranged 
from basic salt solutions to completely defined growth media.  Through the two 
portions of this study, we have demonstrated the importance of culture media on 
the growth of the resulting embryos and ICM explants.  One of the necessary 
macromolecule ingredients for embryo culture media is protein.  Embryos are 
constantly growing and dividing and need to have access to proteins and amino 
acids in order to continue their growth.  It has long been known that BSA and 
FBS are needed in sequence for domestic cat embryonic culture.  Generally in cat 




culture.  However, serum is an unknown biological fluid that may have 
components that are not yet fully understood.  Serum contains three types of 
proteins: globulins, albumin and fibrinogen.  Purified BSA contains mainly 
albumin, while FBS contains mainly fibrinogen, and human serum protein 
substitute  (used in Medium A) contains mainly globulins.  In Study 1, we 
determined that human serum protein substitute (containing α and β globulins) 
could provide an adequate protein source for domestic cat embryos, resulting in 
embryo development similar to that obtained using FBS and BSA.  Moreover, 
human serum protein substitute’s globulin could be used as a protein source for 
all stages and steps of culture.  No change in protein source was necessary for the 
growth of embryos between maturation and fertilization.  Maturation rates were 
not different between the serum protein substitute containing medium and the 
BSA containing medium, unlike in a previous study where FBS was used in place 
of BSA for maturation, resulting in limited expansion of cumulous and decreased 
fertility (Wood et al., 1995). The constituents of serum beg deeper investigation, 
as many of its components are still undefined.  
The components in serum may also have an effect on the culture of 
embryonic stem cells.  Serum can differ between lots, in some cases containing 
factors that may promote differentiation.  Knockout Serum Replacer (KSR) is 
used in place of serum as a defined nutrient source that contains serum proteins 
and associated lipids that have proven helpful in the culture of hESCs and mESCs 
(Garcia-Gonzalo et. al., 2008; Hao et al., 2006).  In Study 2, we explanted ICM 




into three different culture conditions supplemented with serum replacer.  We 
found no significant difference between the growth of explants in these trials, 
however more trials are necessary to truly elucidate any subtle differences. 
The 3i condition was hypothesized to be the superior medium that would 
stimulate the growth of ES-like explants of the naïve subtype due to the addition 
of chemical inhibitors, rather than relying on biological molecules that may be 
species specific.  However, in this study the 3i condition trended to be the worst 
condition for growth.  Because the 3i condition is meant to simulate a mouse like 
condition, the addition of LIF may help aid in the stimulation of pluripotency 
pathways in future experiments. An evaluation of the cat LIF protein and receptor 
(LIFR) could reveal which species of LIF (human or mouse) would be most 
active for the cat LIFR, as was done for the dog (Wilcox et al., 2009). 
The cat condition containing LIF and bFGF was hypothesized to be the 
best at deriving ES-like cells for the domestic cat based on the current literature, 
however, it performed similarly to the mouse condition.  Human ESCs are 
dependent on FGF; it can increase proliferation in these cells when grown on a 
feeder layer and it promotes the ERK and PI-3K pathways (Amit et al., 2000; 
Dvorak et al., 2005; Honda et al., 2009; Wang et al., 2005; Xu et al., 2005).  
Mouse ESCs are not dependent on FGF, therefore, we can make the assumption 
that if this condition had fared best, the cells we obtained would have been more 
like the EpiSC state, and not the naive state. 
The mouse condition permitted establishment of large colonies (30% of 




MAPK pathway and extend self-renewal (Qi et al., 2004; Xu et al., 2002; Ying et 
al., 2003).  This condition produced the best looking colony, which had a tight 
edge, intense OCT-4 immunostaining, and tightly packed cells.  If explants prefer 
this condition while exhibiting pluripotency proteins and mRNA, it is a promising 
sign that they are of the naïve type, like mESCs.  OCT-4 mRNA and protein were 
present; however the results for NANOG are inconclusive.  Further examination 
of this condition is necessary, and mandates better methods to visualize NANOG. 
Due to the lack of significant results, none of these three conditions can be 
said to provide ideal conditions for domestic cat naïve ESC-like explants.  Naïve 
or ground-state ESCs are characterized by the ability to become any type of cell 
present in the three germ layers (including germ cells), maintain pluripotency 
markers, self-renewal capabilities, and have a normal karyotype.  We have shown 
that these explants expressed proteins for OCT-4 and SOX2 in both the mouse 
and cat conditions: however the predominant morphology appeared to be that of 
TE.  Future work is needed to better define the ideal culture conditions of 
domestic cat naïve ES-like explants. 
To better our explant results, several recommendations can be made for 
future experimentation.  The mechanical isolation technique led some blastocysts 
to collapse and for the ICM to become indistinguishable from TE cells.  This 
resulted in a portion of TE being explanted along with the ICM region.  
Significant improvements in ESC derivation might be obtained if the TE can be 
completely removed and only the ICM region explanted because TE has been 




secrete retinoic acid which causes differentiation of the ICM into epiblast and 
primitive endoderm (Parrow et al., 1998; Trout et al., 1991; Yelich et al., 1997).  
Therefore, in the future, an alternative method that completely removes the TE, 
such as immunosurgery of TE with lysis of the labeled cells, should be attempted.  
Although both techniques have been successful for explants in the mouse and 
other species, removal of the TE may prove more beneficial in the cat.  
Another essential component of success is having the appropriate markers 
to determine the quality of the ICM and explants, as well as of the starting 
blastocyst.  OCT-4, an essential pluripotency factor found in embryos and ESCs, 
is an excellent marker for both mRNA and protein.  NANOG however, has 
proven to be very difficult to study; immunostaining is rarely shown in the 
literature.  We had moderate success with the ICC of NANOG in embryos, and 
poor results due to high background in explants.  Quantifying mRNA was 
troublesome due to contamination and inadequate primers.  The trouble with 
visualizing NANOG protein could be due to the loss of expression of NANOG 
with continued embryo culture.  Similarly, having a complete picture of SOX2 
would enable us to make better conclusions about the state of our explants.  A 
decent anti-SOX2 antibody would be useful to produce a more complete picture.  
Unfortunately when working in new species the process of confirming new 
antibodies can be slow and tedious.  Other pluripotency markers such as REX1 or 
KLF4 could be used to increase our panel of genes to assess. 
The type of feeder layer can also play a large role in the success of cell 




fibroblasts were superior to mouse feeder cells (Gómez et al., 2010), other species 
have different results.  In the pig, homogenous feeder cells were better for starting 
initial cultures but mouse proved better for maintenance (Strojeck et al., 1990).  
For dog ES-like cells, homologous and heterologous feeders equally supported 
initial cultures, but mouse feeder cells were superior for continued growth 
(Wilcox et al., 2009).  There are cell-surface and soluble factors provided by the 
feeder layer that allow the embryonic stem cells to prosper.  The optimal 
conditions for deriving novel ESC lines may differ from those required for 
maintenance, and there may be more beneficial types of homologous feeder 
layers.  We used a cat fetal fibroblast layer that perhaps was inferior to the cat 
dermal fibroblast line obtained by other labs. Furthermore, cytokines can have 
dramatic effects on feeder cell morphology – artificial matrixes may eventually 
prove superior to current co-cultures. 
Alternative avenues must also be investigated, such as pursuing induced 
pluripotent stem cells (iPSCs). These cells are generated by reprogramming 
somatic cells, forcing them to express the pluripotency transcription factors, thus 
converting the cell to an ES-like state. The resulting cells can be differentiated in 
the three germ layers as well. One of the benefits of iPSCs is the ability to 
generate these cells from any cell type, i.e. an embryo is not necessary.  Another 
technique that is of value is the production of embryos from somatic cell nuclear 
transfer (SCNT).  SCNT embryos are produced by removing the nuclei of a donor 
cell and placing it into an enucleated egg.  These techniques could provide a way 




are scarce and valuable. ESC from these species could be generated for medical 
and research purposes, and, more specifically, converting these stem cells into 
gametes as an alternative method for preserving rare genomes (Byrne et al., 
2007).   
 In summary, we have shown that commercially available media for in 
vitro culture can be used to produce domestic cat embryos of good quality.  
Human serum protein substitute can be used during maturation as well as 
fertilization and culture with equivalently good results as BSA and FBS.  These 
embryos express NANOG, OCT-4 and SOX2.  The ICM regions of these 
embryos can be mechanically isolated and cultured for two weeks on a CEF 
feeder layer and still maintain the expression of OCT-4 and SOX2 under three 
separate growth conditions.  Refining the cytokine concentrations and cocktails 
could help to determine the relevant pathways of pluripotency in the cat, and these 
data could be extrapolated to more exotic felines, increasing our ability to work 
with the embryos and potential ESCs of rare cats.  More work is needed to 
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